Digital Hive Mind was recently contracted by Taiho Oncology Europe for product photography to support the launch of LYTGOBI in Italy.
Taiho Oncology Europe, a subsidiary of Tokyo-based Taiho Pharmaceutical Co., announced February 12, 2025 the availability of LYTGOBI in Italy for the treatment of metastatic intrahepatic cholangiocarcinoma (bile duct cancer within the liver) in adult patients. LYTGOBI is the first medicine launched by Taiho Oncology Europe.
